A research study spearheaded by 23andMe has uncovered new genetic associations for a group of rare blood cancers offering insights into these sometimes fatal conditions. Published in the journal Blood...

Editor’s note: This post has been edited from its original to reflect changes in 23andMe’s product. We’re posting a story about one of the participants in 23andMe’s MPN Research Initiative...

Dr. Ross Levine Last year 23andMe launched a Myeloproliferative Neoplasms Research Initiative to study this group of rare blood cancers. We are now very close to reaching our goal of...

by Ashley Gould Vice President Corporate Development & Chief Legal Officer, 23andMe Linda Avey and Anne Wojcicki created 23andMe based on a number of visions. They described one of these...